Award
Delivery Order #36C24926N0543
Delivery Order for BREYANZI CAR-T Therapy by Bristol-Myers Squibb
Buyer
Department of Veterans Affairs
Award Amount
$364,139.25
Ceiling
$364,139.25
Awarded
June 22, 2026
Period of Performance
Jun 22, 2026 – Sep 25, 2026
Identifier
36C24926N0543
NAICS
325412
This award is a delivery order contract issued to Bristol-Myers Squibb Company, a leading pharmaceutical firm known for its innovative medical products. The contract procures BREYANZI CAR-T, a specialized cell therapy used in oncology. This delivery order supports the Department of Veterans Affairs' ongoing pharmaceutical supply needs under a broader fixed-price schedule contract. Bristol-Myers Squibb's role in providing this advanced therapy is significant for enhancing treatment options available to veterans, reflecting the agency's commitment to cutting-edge healthcare solutions. The scope includes the delivery of specified quantities of BREYANZI CAR-T to be performed over a multi-month period. The contract is a follow-on order stemming from a substantial federal supply schedule agreement awarded competitively to Bristol-Myers Squibb, emphasizing a reliable supply chain. The performance period is set for a few months within 2026, ensuring timely availability of this critical therapy to the VA.
Description
BREYANZI CAR-T